Listen

Description

Have an idea for an episode? Contact us!

David Weinkove, CEO of Magnitude Biosciences joins us to talk to us about their work with C. elegans- tiny worms used to test compounds for health. We learn about the difference between a lifespan and a healthspan and how using these tiny worms to study the effects of compounds on aging is helpful.  David shares Magnitude's work as a CRO and how they translate their work into an industrial setting. Finally, find out a cool fact you might not have known about worms. Stay through to the very end for a thought exercise for our audience. That's right- he gave us homework!

Magnitude Biosciences is an Innovation AveNEW company at SLAS2022 who help industry and academia progress their research projects via a team of expert scientists, C. elegans services and unique automated imaging technology.

Why worms? Check out this awesome graph explaining why. 

Upcoming Events:

SLAS Europe 2026 Conference and Exhibition (19-21 May 2026 | Vienna, Austria)

SLAS Meet-Ups

SLAS 2026 Sample Management Symposium (October 21-22, 2026 | South San Francisco, California)

SLAS2027 International Conference & Exhibition (January 30 - February 3, 2027 | San Diego, California)

View the full events calendar